ACHE and Alzheimer disease: Accordingly, despite the ability of AchE inhibitors to delay cognitive decline and improve neuropsychiatric symptoms, it is nonetheless necessary to re-recognize the role played by the cholinergic system in AD progression, especially during the early stages of the disease.